Ensure adequate fluid intake and contact your GP if symptoms are severe or prolonged Changes in mood or mental health : Whilst sertraline treats depression and anxiety, any worsening of mental health symptoms, emergence of suicidal thoughts, or unusual behavioural changes should be reported immediately Appetite changes : Significant loss of appetite or difficulty eating adequate nutrition requires medical review Signs of pancreatitis : Severe abdominal pain radiating to the back, nausea, and vomiting warrant urgent medical assessment, as GLP-1 agonists carry a small risk of pancreatitis [1] [5] Gallbladder problems : Wegovy and rapid weight loss can increase the risk of gallstones and gallbladder inflammation
Were committed to providing expert guidance and effective solutions to help you take control of your health and feel your best
Driven by a 10-year, 3-step plan created and publicized by Novo Nordisk to build the ob*sity care market from scratch to maximize their GLP-1 weight loss drug profits (which Louise Adams and I will discuss in-depth on our podcast), we have seen a combination of factors including (but certainly not limited to): Astroturf patient-advocacy groups working hard to influence not just patient and provider behavior, but also public health messaging, government and policy Extremely sketchy research creating misleading messages everything from body size itself, to the realities of the drugs, to how much weight is regained when people go off the drugs and much, much more Education created by the weight loss industry delivered directly to healthcare providers Its no wonder that there is so much confusion about informed consent for these drugs
S., Diaspro, A
Patients should be committed to healthy lifestyle changes like a reduced-calorie diet and exercise so they can successfully lose weight and maintain their results
Barriers and facilitators for type-2 diabetes management in South Asians: a systematic review
